Cellulite

Cellulite, scientifically known as gynoid lipodystrophy or edematous-fibrosclerotic panniculopathy, is a common topographical skin condition characterized by a dimpled or uneven surface appearance, primarily occurring on the thighs and buttocks of post-pubertal women (StatPearls, 2023). It is not a single molecular target but a multifactorial condition involving the herniation of subcutaneous fat into the dermis, structural changes in the fibrous connective tissue septae, and microcirculatory dysfunction (PubMed, 2015). Pharmacological treatments often focus on modifying the structural components of the skin or fat; for example, collagenase clostridium histolyticum is an FDA-approved enzyme that targets and breaks down the collagen-rich fibrous bands that pull on the skin to create dimples (FDA, 2020). Other topicals like caffeine or retinoids aim to stimulate lipolysis or thicken the dermis, respectively, to mask the appearance of underlying fat lobules (AAD, 2023). Because cellulite represents a complex architectural change in tissue rather than a specific receptor or enzyme, it is classified as a clinical condition rather than a discrete molecular therapeutic target.

Other names

Gynoid lipodystrophyEdematous-fibrosclerotic panniculopathyOrange peel skinCottage cheese skinAdiposis edematosaStatus protrusionis cutis

Enzymatic degradation of collagen Type I and Type III in fibrous septae (by collagenase); inhibition of phosphodiesterase to increase cAMP and promote lipolysis (by methylxanthines); stimulation of collagen production and dermal thickening (by retinoids).